SCHEMBL24754667

SCHEMBL24754667

Cc1cc2ccccc2n1Cc1ccc(C(=O)NO)cc1F

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 10/20 0.69
HDAC1 Q13547 8/20 0.69
HDAC8 Q9BY41 4/20 0.69
HDAC2 Q92769 3/20 0.69
HDAC4 P56524 3/20 0.69
HDAC9 Q9UKV0 2/20 0.69
HDAC10 Q969S8 2/20 0.69
HDAC11 Q96DB2 2/20 0.69
HDAC3 O15379 1/20 0.69
HDAC7 Q8WUI4 1/20 0.69
HDAC5 Q9UQL6 1/20 0.69
MAPT P10636 5/20 0.50
SMN1; SMN2 Q16637 4/20 0.50
TP53 P04637 2/20 0.50
POLB P06746 1/20 0.50
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
NPC1 O15118 1/20 0.48
ALDH1A1 P00352 1/20 0.48
CYP1A2 P05177 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22110373 0.82 HDAC6 (1.00) HDAC6HDAC1HDAC8HDAC2HDAC4
SCHEMBL12472553 0.82 HDAC6 (1.00) HDAC6HDAC1HDAC8HDAC2HDAC4
SCHEMBL12938881 0.82 HDAC6 (0.68) HDAC6HDAC1HDAC8HDAC2HDAC4
SCHEMBL10413206 0.77 L3MBTL1 (0.54) HDAC6HDAC1HDAC8HDAC2HDAC9
SCHEMBL15705724 0.72 HDAC6 (0.81) HDAC6HDAC1HDAC8HDAC2HDAC9
SCHEMBL23951042 0.71 HDAC6 (0.73) HDAC6HDAC1HDAC8HDAC2HDAC4
SCHEMBL24031084 0.70 HDAC6 (1.00) HDAC6HDAC1HDAC8HDAC11
SCHEMBL29382989 0.70 HDAC6 (1.00) HDAC6HDAC1HDAC8HDAC11
SCHEMBL4056126 0.70 HDAC6 (0.74) HDAC6HDAC1HDAC8HDAC2HDAC9
SCHEMBL12472344 0.69 HDAC6 (0.73) HDAC6HDAC1HDAC8HDAC2HDAC9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220401474-A1 HDAC6-ACTIVATED MACROPHAGES, COMPOSITIONS, AND USES THEREOF MEDSTAR HEALTH 2022-12-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220401474-A1 HDAC6-ACTIVATED MACROPHAGES, COMPOSITIONS, AND USES THEREOF HDAC6, HDAC1, HDAC3 HDAC6 1/4885HDAC1 2/4885HDAC8 6/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.